CHAMISHI THERAPEUTICS
Chamishi Therapeutics, a drug discovery and development company focused on neurodegenerative diseases and other related disorders. Chamishi will initially focus on developing antisense oligonucleotide (ASO) therapies for Glucosylceramidase Beta Acid (GBA)-Parkinson’s disease.
CHAMISHI THERAPEUTICS
Industry:
Biopharma Biotechnology
Founded:
2019-01-01
Address:
Deerfield, Illinois, United States
Country:
United States
Total Employee:
51+
Status:
Active
Contact:
630-336-3541
Total Funding:
490.39 K USD
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
More informations about "Chamishi Therapeutics"
The Silverstein Foundation and Q-State Biosciences Launch …
Sep 25, 2019 The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences today announced the formation and launch of Chamishi Therapeutics, a drug discovery and …See details»
Treating Parkinson’s with GBA Mutations Focus of …
Oct 3, 2019 Chamishi will initially focus on developing antisense oligonucleotide (ASO) therapies for Parkinson’s patients carrying mutations in the GBA gene, one of this disease’s most common and significant genetic risk factors. “We are at …See details»
Initiatives - Silverstein Foundation
September 2019. The Silverstein Foundation, along with Q-State Biosciences launched Chamishi Therapeutics, a drug discovery and development company focused on neurodegenerative …See details»
ASO Therapies for Parkinson’s With GBA Mutations Ready for …
Feb 10, 2021 These ASO candidates are designed for patients carrying mutations in the GBA gene, a key genetic risk factor for the disease’s development.. Their development is the first …See details»
Chamishi Therapeutics - Crunchbase Company Profile & Funding
Chamishi Therapeutics, a drug discovery and development company focused on neurodegenerative diseases and other related disorders. Chamishi will initially focus on …See details»
Q-State Biosciences Announces Achievement of Key Research …
Chamishi Therapeutics is a drug discovery and development company focused on precision therapies for neurodegenerative diseases and other related diseases. ... The Silverstein …See details»
2019 - Silverstein Foundation
The Silverstein Foundation and Q-State Biosciences Launch Chamishi Therapeutics NEW YORK and CAMBRIDGE, Mass., Sept 26, 2019 (GLOBE NEWSWIRE) – The Silverstein Foundation …See details»
The Silverstein Foundation and Q-State Biosciences Launch …
Sep 26, 2019 NEW YORK and CAMBRIDGE, Mass., Sept. 26, 2019 -- The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences today announced the formation …See details»
Q-State Biosciences Announces Achievement of Key …
Feb 8, 2021 Chamishi Therapeutics is a drug discovery and development company focused on precision therapies for neurodegenerative diseases and other related diseases. ... non-profit organization focused on ...See details»
Chamishi Therapeutics - Products, Competitors, Financials, …
About Chamishi Therapeutics Chamishi Therapeutics is a drug discovery and development company focused on precision therapies for neurodegenerative diseases and other related …See details»
The Silverstein Foundation and Q-State Biosciences Launch
Sep 26, 2019 Chamishi Therapeutics is a drug discovery and development company focused on precision therapies for neurodegenerative diseases and other related diseases. ... non-profit …See details»
The Silverstein Foundation and Q-State Biosciences Launch …
Sep 26, 2019 NEW YORK and CAMBRIDGE, Mass., Sept. 26, 2019 -- The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences today announced the formation …See details»
Research programme : antisense oligonucleotide therapeutics
26 Sep 2019 The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences launch Chamishi Therapeutics for development of antisense oligonucleotide therapies for …See details»
The Silverstein Foundation and Q-State Biosciences Launch …
Sep 26, 2019 The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences today announced the formation and launch of Chamishi Therapeutics, a drug discoverySee details»
Q-State Biosciences Announces Achievement of Key Research …
Feb 8, 2021 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Q-State Biosciences, a technology-derived medicines company, today announced that it has achieved the primary program …See details»
Chamishi Therapeutics - Funding, Financials, Valuation & Investors
Chamishi Therapeutics is a drug discovery and development company focused on neurodegenerative diseases and other related disorders. Search Crunchbase. ... How much …See details»
Q-State Biosciences Announces Achievement of Key Research …
Feb 8, 2021 Chamishi Therapeutics is a drug discovery and development company focused on precision therapies for neurodegenerative diseases and other related diseases. ... non-profit …See details»
The Silverstein Foundation and Q-State Biosciences Launch …
Sep 26, 2019 NEW YORK and CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences to...See details»
Chamishi Therapeutics - Contacts, Employees, Board Members
Organization. Chamishi Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Chamishi …See details»
Q-State Biosciences Announces Achievement of Key Research …
Feb 8, 2021 Chamishi Therapeutics is a drug discovery and development company focused on precision therapies for neurodegenerative diseases and other related diseases. ... The …See details»